Urinary podocyte excretion as a marker for preeclampsia

American Journal of Obstetrics and Gynecology - Tập 196 Số 4 - Trang 320.e1-320.e7 - 2007
Vesna D. Garovic1, Steven J. Wagner1, Stephen T. Turner1, David W. Rosenthal1, William J. Watson2, Brian Brost2, Carl H. Rose2, Larisa Gavrilova2, Paula Craigo3, Kent R. Bailey4, Johannes Achenbach5, Mario Schiffer5, Joseph P. Grande1
1Divisions of Nephrology & Hypertension, Mayo Clinic, Rochester, MN
2Divisions of Obstetrics and Gynecology, Mayo Clinic, Rochester, MN
3Department of Anesthesia, Mayo Clinic, Rochester, MN;
4Department of Biostatistics, Mayo Clinic, Rochester, MN
5Department of Nephrology, Hannover Medical School, Hannover, Germany

Tóm tắt

Từ khóa


Tài liệu tham khảo

2000, Report of the National High Blood Pressure Education Program Working Group on high blood pressure in pregnancy [see comment], Am J Obstet Gynecol, 183, S1

Schiffer, 2001, Apoptosis in podocytes induced by TGF-beta and Smad7, J Clin Investig, 108, 807, 10.1172/JCI200112367

Kihara, 1997, Podocyte detachment and epithelial cell reaction in focal segmental glomerulosclerosis with cellular variants, Kidney Int Suppl, 63, S171

Yu, 2005, Urinary podocyte loss is a more specific marker of ongoing glomerular damage than proteinuria, J Am Soc Nephrol, 16, 1733, 10.1681/ASN.2005020159

Nakamura, 2000, Urinary podocytes for the assessment of disease activity in lupus nephritis, Am J Med Sci, 320, 112, 10.1097/00000441-200008000-00009

Jones, 1998, HELLP! A cry for laboratory assistance: a comprehensive review of the HELLP syndrome highlighting the role of the laboratory, Hematopathol Mol Hematol, 11, 147

DeLong, 1988, Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach, Biometrics, 44, 837, 10.2307/2531595

Petermann, 2003, Podocytes that detach in experimental membranous nephropathy are viable [see comment], Kidney Int, 64, 1222, 10.1046/j.1523-1755.2003.00217.x

Vogelmann, 2003, Urinary excretion of viable podocytes in health and renal disease, Am J Physiol Renal Physiol, 285, F40, 10.1152/ajprenal.00404.2002

Kershaw, 1997, Molecular cloning and characterization of human podocalyxin-like protein: orthologous relationship to rabbit PCLP1 and rat podocalyxin, J Biol Chem, 272, 15708, 10.1074/jbc.272.25.15708

Kikuno, 1999, Prediction of the coding sequences of unidentified human genes: XIV, the complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro, DNA Res, 6, 197, 10.1093/dnares/6.3.197

Garovic VD, Wagner SJ, Petrovic LM, et al. Glomerular expression of nephrin and synaptopodin, but not podoan, is decreased in kidney sections from women with preeclampsia. Nephrol Dial Transplant 2007 [Epub ahead of print].

Maynard, 2003, Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia [see comment], J Clin Investig, 111, 649, 10.1172/JCI17189

Park, 2005, An elevated maternal plasma, but not amniotic fluid, soluble fms-like tyrosine kinase-1 (sFlt-1) at the time of mid-trimester genetic amniocentesis is a risk factor for preeclampsia, Am J Obstet Gynecol, 193, 984, 10.1016/j.ajog.2005.06.033

Levine, 2004, Circulating angiogenic factors and the risk of preeclampsia [see comment], N Engl J Med, 350, 672, 10.1056/NEJMoa031884

Chaiworapongsa, 2004, Evidence supporting a role for blockade of the vascular endothelial growth factor system in the pathophysiology of preeclampsia: Young Investigator Award, Am J Obstet Gynecol, 190, 1541, 10.1016/j.ajog.2004.03.043

Levine, 2005, Urinary placental growth factor and risk of preeclampsia [see comment], JAMA, 293, 77, 10.1001/jama.293.1.77

Levine, 2006, Soluble endoglin and other circulating antiangiogenic factors in preeclampsia [see comment; erratum appears in N Engl J Med. 2006;355:1840], N Engl J Med, 355, 992, 10.1056/NEJMoa055352